Wii Balance Board in Dizziness

This study has been withdrawn prior to enrollment.

(The study never started since it did not receive IRB approval)

Sponsor:

Information provided by (Responsible Party):

Kaiser Permanente

ClinicalTrials.gov Identifier:

NCT01345422

First received: April 28, 2011

Last updated: December 7, 2015

Last verified: December 2015

History of Changes

Purpose

Patients with dizziness presently undergo physical therapy rehabilitation. Our study will study whether Wii Balance Board made by Nintendo Inc. will be helpful in patients with dizziness. They will undergo dizziness evaluation to quantify their dizziness.

Condition	Intervention
Dizziness	Other: Wii Balance Board


Study Type:	Interventional
Study Design:	Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Supportive Care
Official Title:	A Pilot Study to Assess the Usefulness of the Wii Balance Board for Dizziness

Resource links provided by NLM:

MedlinePlus related topics: Dizziness and Vertigo

U.S. FDA Resources

Further study details as provided by Kaiser Permanente:


Enrollment:	0

Arms	Assigned Interventions
Experimental: Wii Balance Board Wii Balance Board Training	Other: Wii Balance Board Participant will undergo Nintendo Wii Balance Board training for two months , five days a week for 30 minutes

Eligibility


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Abnormal posturography exam

Exclusion Criteria:

Pregnant Women and children

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01345422

Sponsors and Collaborators

Kaiser Permanente

Investigators


Principal Investigator:	David Cheng, MD	Southern California Permanente Medical Group

More Information


Responsible Party:	Kaiser Permanente
ClinicalTrials.gov Identifier:	NCT01345422 History of Changes
Other Study ID Numbers:	HNS1
Study First Received:	April 28, 2011
Last Updated:	December 7, 2015
Health Authority:	United States: Institutional Review Board
Individual Participant Data
Plan to Share IPD:	No
Plan Description:	this study did not receive IRB approval

Additional relevant MeSH terms:


Dizziness Vertigo Sensation Disorders Neurologic Manifestations Nervous System Diseases	Signs and Symptoms Vestibular Diseases Labyrinth Diseases Ear Diseases Otorhinolaryngologic Diseases

ClinicalTrials.gov processed this record on September 27, 2016

To Top